Laura Lawrence Selected Research

delafloxacin

8/2020	Efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from the Delafloxacin Phase 3 CABP Trial.
1/2020	Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial.
1/2020	A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP).
1/2018	Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function.
1/2018	Pharmacokinetics of Intravenous Delafloxacin in Patients With End-Stage Renal Disease.
1/2018	Clinical Pharmacokinetics of Sulfobutylether-β-Cyclodextrin in Patients With Varying Degrees of Renal Impairment.
1/2018	A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.
1/2015	A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Lawrence Research Topics

Disease

4	Infections 08/2020 - 01/2015
3	Bacterial Pneumonia 08/2020 - 01/2020
2	Diarrhea 01/2018 - 01/2015
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 01/2018
1	Pneumonia (Pneumonitis) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2018
1	Nausea 01/2015
1	Abscess 01/2015
1	Vomiting 01/2015
1	Wound Infection (Wound Infections) 01/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Cellulitis 01/2015
1	Burns 01/2015
1	Insect Bites and Stings (Insect Bite) 01/2015

Drug/Important Bio-Agent (IBA)

8	delafloxacinIBA 08/2020 - 01/2015
3	Moxifloxacin (Avelox)FDA Link 08/2020 - 01/2020
2	FluoroquinolonesIBA 01/2020 - 01/2018
1	AntigensIBA 08/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Aztreonam FDA LinkGeneric 01/2018
1	CreatinineIBA 01/2018
1	Vancomycin FDA LinkGeneric 01/2018
1	Tigecycline (Tygacil)FDA Link 01/2015

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 01/2018 - 01/2018
1	Intravenous Infusions 01/2018